Related Experiment Video
Updated: Jan 13, 2026

Mapping Dysfunctional Protein-Protein Interactions in Disease
Published on: October 24, 2025
Nonmodified Strategy Enabled Proteome-Wide Mapping of Catechol Derivatives Interactome
Zichun Qiao1,2, Xiaozhe Zhang1, He Wang1,2
1State Key Laboratory of Medical Proteomics, National Chromatographic R. & A. Center, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian 116023, China.
This study introduces a novel, modification-free method (OABA) to map how catechol compounds interact with proteins directly in living cells. This approach advances understanding of polyphenol pharmacology by revealing native protein interactions without altering drug molecules.
Area of Science:
- Chemical Biology
- Pharmacology
- Proteomics
Background:
- Understanding catechol derivative pharmacology requires profiling their protein interactions.
- Current methods for target identification often involve ligand modification or protein perturbation, limiting comprehensive interactome coverage.
Purpose of the Study:
- To develop a modification-free strategy for mapping catechol-protein interactions in native cellular environments.
- To enable direct analysis of the interactome of catechol-containing compounds.
Main Methods:
- Developed oxidative addition-boronate affinity enrichment (OABA), a redox-enabled technique.
- Utilized catechol oxidation to ortho-quinones for covalent protein capture.
- Employed boronate affinity recognition for selective enrichment of catechol-protein adducts.
Main Results:
- Demonstrated proof-of-concept with isoproterenol (ISO), achieving 2-fold enrichment of SOD1-adduct peptides.
- Identified 74 high-confidence quercetin interactors in live HeLa cells.
- Validated interactions with FDPS, CCT7, and CS using molecular docking and CETSA.
Conclusions:
- OABA provides a reliable, modification-free platform for mapping native catechol-protein interactomes.
- This method advances the understanding of polyphenolic pharmacology.
- Facilitates direct mapping of drug-protein interactions in living systems.
More Related Videos
11:19Label-Free Immunoprecipitation Mass Spectrometry Workflow for Large-scale Nuclear Interactome Profiling
Published on: November 17, 2019
14:44A Protocol for the Identification of Protein-protein Interactions Based on 15N Metabolic Labeling, Immunoprecipitation, Quantitative Mass Spectrometry and Affinity Modulation
Published on: September 24, 2012